Economic burden assessment for the management of asthma patients at Mexico’s National Institute for Respiratory Diseases
Background. In Mexico, asthma is one of the top twenty causes of disease with 254,713 new cases reported in 2019. According to Phase 3 of the International Study of Asthma and Allergies in Childhood, the prevalence of asthma ranged from 5 to 14% in 6 Mexican cities with varied geographic conditions...
主要な著者: | , , , , , , , , , , |
---|---|
フォーマット: | 論文 |
言語: | English |
出版事項: |
Colegio Mexicano de Inmunología Clínica y Alergia, A.C.
2024-04-01
|
シリーズ: | Revista Alergia México |
主題: | |
オンライン・アクセス: | https://revistaalergia.mx/ojs/index.php/ram/article/view/1279 |